MARCH Proteins, Members of a Host Protein Family that Targets HIV-1

MARCH 蛋白,靶向 HIV-1 的宿主蛋白家族成员

基本信息

项目摘要

Project Summary/ Abstract Membrane Associated RING CH (MARCH) proteins are RING E3 ubiquitin ligases that are implicated in the regulation of membrane receptors. This family of ubiquitin ligases emerged after the discovery of K3 and K5, two viral MARCH-homologues in Kaposi’s sarcoma associated herpesvirus (KSHV), which are critical in evading the host’s immune response by ubiquitinating and subsequently removing the major histocompatibility complex class II (MHC-II) receptors from the surface of the cells and therefore blocking antigen presentation. The cellular MARCH family of proteins consists of 11 members that share structural similarity and contain a RING-CH domain that is essential for the removal and internalization of target membrane receptors (e.g. MHC-II). Recent reports showed that MARCH proteins can also potently restrict human immunodeficiency virus 1 (HIV-1) infection. MARCH1, 2 and 8 restrict HIV-1 and other retroviruses by blocking the incorporation of the viral envelope in the budding virions. This proposal explores aspects of the MARCH-mediated antiretroviral mechanism that have never been previously studied. Currently, there is no information concerning a viral protein that counteracts MARCH proteins. The first aim of this research plan examines the mechanism by which an HIV encoded factor counteracts MARCH8 during infection. The second aim examines the susceptibility of HIV-1 envelopes from different subtypes to MARCH-mediated restriction as well as the ability of HIV-1 proteins from different subtypes to counteract MARCH8. Preliminary studies show that HIV-1 over time becomes resistant to MARCH restriction. The third aim will determine the changes in the HIV-1 genome that render it resistant to MARCH inhibition. Finally, the fourth aim will address the role of the other MARCH proteins on HIV-1 infection. In summary, these studies will shed new light on the anti-retroviral role of MARCH proteins and will address aspects of MARCH- mediated HIV-1 inhibition that have not been previously determined. Finally, these proteins have strong potential as clinical targets for the development of antiretroviral therapeutics.
项目总结/摘要 膜相关RING CH(MARCH)蛋白是RING E3泛素连接酶,其涉及细胞膜的形成。 膜受体的调节。这个泛蛋白连接酶家族是在发现K3和K5之后出现的, 卡波西肉瘤相关疱疹病毒(KSHV)中的病毒MARCH同源物,这在逃避 通过泛素化和随后去除主要组织相容性复合物类的宿主免疫应答 II(MHC-II)受体从细胞表面,因此阻断抗原呈递。蜂窝 MARCH蛋白家族由11个成员组成,这些成员具有结构相似性并包含RING-CH结构域 其对于靶膜受体(例如MHC-II)的去除和内化是必需的。最近的报告 研究表明,MARCH蛋白也可以有效地限制人类免疫缺陷病毒1(HIV-1)感染。 MARCH 1、2和8通过阻断病毒包膜结合到 萌芽病毒体该提案探讨了MARCH介导的抗逆转录病毒机制的各个方面, 以前从未被研究过。目前,还没有关于病毒蛋白质的信息, MARCH蛋白。这项研究计划的第一个目标是研究艾滋病毒编码因子的机制, 在感染期间抵消MARCH 8。第二个目的是检查HIV-1包膜的易感性, 不同亚型对MARCH介导的限制以及来自不同亚型的HIV-1蛋白的能力 3月8日,初步研究表明,随着时间的推移,HIV-1会对MARCH限制产生抗药性。 第三个目标是确定HIV-1基因组中使其对MARCH抑制剂具有抗性的变化。 最后,第四个目标将解决其他MARCH蛋白在HIV-1感染中的作用。总而言之, 研究将揭示MARCH蛋白的抗逆转录病毒作用,并将解决MARCH- 介导的HIV-1抑制作用之前尚未确定。最后,这些蛋白质具有强大的潜力, 作为抗逆转录病毒疗法的临床靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Spyridon Stavrou其他文献

Spyridon Stavrou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Spyridon Stavrou', 18)}}的其他基金

Elucidating the role of SERINC5 in SARS-CoV-2 infection
阐明 SERINC5 在 SARS-CoV-2 感染中的作用
  • 批准号:
    10624238
  • 财政年份:
    2022
  • 资助金额:
    $ 39.19万
  • 项目类别:
Elucidating the role of SERINC5 in SARS-CoV-2 infection
阐明 SERINC5 在 SARS-CoV-2 感染中的作用
  • 批准号:
    10372283
  • 财政年份:
    2022
  • 资助金额:
    $ 39.19万
  • 项目类别:
MARCH Proteins, Members of a Host Protein Family that Targets HIV
MARCH 蛋白,针对 HIV 的宿主蛋白家族成员
  • 批准号:
    10402690
  • 财政年份:
    2021
  • 资助金额:
    $ 39.19万
  • 项目类别:
MARCH Proteins, Members of a Host Protein Family that Targets HIV
MARCH 蛋白,针对 HIV 的宿主蛋白家族成员
  • 批准号:
    10543550
  • 财政年份:
    2021
  • 资助金额:
    $ 39.19万
  • 项目类别:
The role of SERINC5 during retrovirus infection in vivo
SERINC5在体内逆转录病毒感染过程中的作用
  • 批准号:
    10082429
  • 财政年份:
    2020
  • 资助金额:
    $ 39.19万
  • 项目类别:
The role of SERINC5 during retrovirus infection in vivo
SERINC5在体内逆转录病毒感染过程中的作用
  • 批准号:
    9887341
  • 财政年份:
    2020
  • 资助金额:
    $ 39.19万
  • 项目类别:
The in vivo function of A3A and A3G during retrovirus infection
A3A和A3G在逆转录病毒感染过程中的体内功能
  • 批准号:
    8456554
  • 财政年份:
    2013
  • 资助金额:
    $ 39.19万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.19万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了